“Efficacy of Dapagliflozin Versus Empagliflozin on Glycemic Control and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus”. World Journal of Current Medical and Pharmaceutical Research, vol. 8, no. 2, Aug. 2026, pp. 185-9, https://doi.org/10.37022/wjcmpr.v8i2.415.